La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Salmones Camanchaca Bilan de santé

Santé financière contrôle des critères 2/6

Salmones Camanchaca possède un total de capitaux propres de $200.7M et une dette totale de $132.5M, ce qui porte son ratio d'endettement à 66%. Son actif total et son passif total sont $430.9M et de $230.3M. L'EBIT de Salmones Camanchaca est $11.2M ce qui fait que son ratio de couverture des intérêts 0.9. Elle dispose de liquidités et de placements à court terme de $14.6M.

Informations clés

66.0%

Ratio d'endettement

US$132.53m

Dette

Ratio de couverture des intérêts	0.9x
Argent liquide	US$14.60m
Fonds propres	US$200.67m
Total du passif	US$230.27m
Total des actifs	US$430.95m

Mises à jour récentes de la santé financière

Recent updates

Salmones Camanchaca (SNSE:SALMOCAM) Is Carrying A Fair Bit Of Debt

Mar 21

Salmones Camanchaca (SNSE:SALMOCAM) Is Making Moderate Use Of Debt

Oct 14

A Look At The Intrinsic Value Of Salmones Camanchaca S.A. (SNSE:SALMOCAM)

May 19

Tread With Caution Around Salmones Camanchaca S.A.'s (SNSE:SALMOCAM) 3.2% Dividend Yield

Mar 24

Salmones Camanchaca's(SNSE:SALMOCAM) Share Price Is Down 21% Over The Past Year.

Jan 28

Would Salmones Camanchaca (SNSE:SALMOCAM) Be Better Off With Less Debt?

Dec 12

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de SALMOCAM ( $286.9M ) dépassent ses passifs à court terme ( $102.6M ).

Passif à long terme: Les actifs à court terme de SALMOCAM ( $286.9M ) dépassent ses passifs à long terme ( $127.6M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de SALMOCAM ( 58.8% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de SALMOCAM est passé de 51% à 66% au cours des 5 dernières années.

Couverture de la dette: La dette de SALMOCAM n'est pas bien couverte par le flux de trésorerie opérationnel ( 4.5% ).

Couverture des intérêts: Les paiements d'intérêts de SALMOCAM sur sa dette ne sont pas bien couverts par l'EBIT ( 0.9 x couverture).

Salmones Camanchaca Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Oslo Børs Decides to Delist Salmones Camanchaca with Last Day of Trading on October 28, 2024

Salmones Camanchaca S.A. Common Shares to be Deleted from OTC Equity

Salmones Camanchaca (SNSE:SALMOCAM) Is Carrying A Fair Bit Of Debt

Salmones Camanchaca (SNSE:SALMOCAM) Is Making Moderate Use Of Debt

Would Salmones Camanchaca (SNSE:SALMOCAM) Be Better Off With Less Debt?

Recent updates

Oslo Børs Decides to Delist Salmones Camanchaca with Last Day of Trading on October 28, 2024

Second quarter 2024 earnings released: EPS: US$0.097 (vs US$0.026 loss in 2Q 2023)

New major risk - Financial position

First quarter 2024 earnings released: US$0.017 loss per share (vs US$0.11 profit in 1Q 2023)

Less than half of directors are independent

Salmones Camanchaca S.A. Common Shares to be Deleted from OTC Equity

Full year 2023 earnings released: US$0.081 loss per share (vs US$0.60 profit in FY 2022)

Salmones Camanchaca S.A. Provides Production Guidance for the Year of 2024

Salmones Camanchaca S.A., Annual General Meeting, Apr 19, 2024

New major risk - Financial position

Third quarter 2023 earnings released: US$0.074 loss per share (vs US$0.25 profit in 3Q 2022)

New minor risk - Financial position

Second quarter 2023 earnings released: US$0.026 loss per share (vs US$0.23 profit in 2Q 2022)

Salmones Camanchaca S.A. to Report First Half, 2023 Results on Aug 16, 2023

Salmones Camanchaca S.A. Provides Production Guidance for the Year 2023

First quarter 2023 earnings released: EPS: US$0.11 (vs US$0.022 in 1Q 2022)

Upcoming dividend of US$0.33 per share at 3.7% yield

Full year 2022 earnings released: EPS: US$0.60 (vs US$0.13 loss in FY 2021)

Salmones Camanchaca S.A. Provides Production Guidance for the Full Year 2023

Salmones Camanchaca S.A., Annual General Meeting, Apr 21, 2023

Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.069 in 3Q 2021)

Less than half of directors are independent

Salmones Camanchaca S.A. Provides Production Guidance for the Year 2022 and 2023

Salmones Camanchaca S.A. Maintains Harvest Estimate for 2022

Second quarter 2022 earnings released: EPS: US$0.23 (vs US$0.13 loss in 2Q 2021)

First quarter 2022 earnings released: EPS: US$0.022 (vs US$0.23 loss in 1Q 2021)

Salmones Camanchaca S.A. Provides Production Guidance for the Full Year 2022

Less than half of directors are independent

Salmones Camanchaca S.A. Provides Production Guidance for the Full Year of 2022 and 2023

Salmones Camanchaca (SNSE:SALMOCAM) Is Carrying A Fair Bit Of Debt

Less than half of directors are independent

Salmones Camanchaca S.A., Annual General Meeting, Apr 22, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Salmones Camanchaca S.A. Provides Production Guidance for the Full Year of 2022

Vice Chairman exercised options to buy CL$3.7m worth of stock.

Third quarter 2021 earnings released: EPS US$0.069 (vs US$0.14 loss in 3Q 2020)

Salmones Camanchaca (SNSE:SALMOCAM) Is Making Moderate Use Of Debt

Second quarter 2021 earnings released: US$0.13 loss per share (vs US$0.25 loss in 2Q 2020)

Salmones Camanchaca S.A. Provides Harvest Estimates for the Full Year 2021

A Look At The Intrinsic Value Of Salmones Camanchaca S.A. (SNSE:SALMOCAM)

First quarter 2021 earnings released: US$0.23 loss per share (vs US$0.028 profit in 1Q 2020)

Salmones Camanchaca S.A. Provides Operating Guidance for the Year 2021

Salmones Camanchaca S.A. Provides Production Guidance for the Year 2021

Salmones Camanchaca S.A. Provides Production Guidance for the Year 2021

Tread With Caution Around Salmones Camanchaca S.A.'s (SNSE:SALMOCAM) 3.2% Dividend Yield

Salmones Camanchaca S.A. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: CL$5,428

Full year 2020 earnings released: US$0.48 loss per share (vs US$0.64 profit in FY 2019)

Revenue misses expectations

Salmones Camanchaca's(SNSE:SALMOCAM) Share Price Is Down 21% Over The Past Year.

New 90-day high: CL$5,377

New 90-day high: CL$4,627

Would Salmones Camanchaca (SNSE:SALMOCAM) Be Better Off With Less Debt?

Salmones Camanchaca Renews Joint Venture Agreement for Trout Production

Third quarter 2020 earnings released: US$0.14 loss per share

Revenue misses expectations

New 90-day low: CL$4,206

New 90-day low: CL$4,364

New 90-day low: CL$4,728

Salmones Camanchaca S.A. to Report Q2, 2020 Results on Aug 20, 2020

First half earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines